Nature Communications (Jan 2023)

Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis

  • Julien Broséus,
  • Sébastien Hergalant,
  • Julia Vogt,
  • Eugen Tausch,
  • Markus Kreuz,
  • Anja Mottok,
  • Christof Schneider,
  • Caroline Dartigeas,
  • Damien Roos-Weil,
  • Anne Quinquenel,
  • Charline Moulin,
  • German Ott,
  • Odile Blanchet,
  • Cécile Tomowiak,
  • Grégory Lazarian,
  • Pierre Rouyer,
  • Emil Chteinberg,
  • Stephan H. Bernhart,
  • Olivier Tournilhac,
  • Guillaume Gauchotte,
  • Sandra Lomazzi,
  • Elise Chapiro,
  • Florence Nguyen-Khac,
  • Céline Chery,
  • Frédéric Davi,
  • Mathilde Hunault,
  • Rémi Houlgatte,
  • Andreas Rosenwald,
  • Alain Delmer,
  • David Meyre,
  • Marie-Christine Béné,
  • Catherine Thieblemont,
  • Peter Lichter,
  • Ole Ammerpohl,
  • Jean-Louis Guéant,
  • ICGC MMML-Seq Consortium,
  • Romain Guièze,
  • José Ignacio Martin-Subero,
  • Florence Cymbalista,
  • Pierre Feugier,
  • Reiner Siebert,
  • Stephan Stilgenbauer

DOI
https://doi.org/10.1038/s41467-022-34642-6
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 19

Abstract

Read online

Richter syndrome (RS) is the transformation of chronic lymphocytic leukaemia (CLL) into aggressive lymphoma, in most cases diffuse large B-cell lymphoma (DLBCL). Here, the authors characterize the DNA methylation and transcriptomic profiles of RS samples, find a clonally-related CLL epigenetic imprint, and develop classifiers for “RS-type” de novo DLBCLs.